Sleep apnoea linked to poorer outcomes from COVID-19, study finds
People with sleep condition could be at an increased risk of adverse outcomes from COVID-19
Read More
Author: Lucy Parsons
ICR study combines precision medicines to treat drug-resistant cancers
Researchers found combination treatment showed promise against a range of cancer types
Read More
GenSight Biologics seeks EU approval for gene therapy
Lumevoq is designed to treat vision loss associated with Leber Hereditary Optic Neuropathy
Read More
NICE unites with global health leaders to highlight evidence-based healthcare
World Evidence-based Healthcare Day takes place on 20 October
Read More
A third of UK doctors have treated COVID-19 patients without full PPE, report finds
Report also highlights the impact of COVID-19 on the physical and mental health of doctors
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
